Skip to content

A clinical trial to study the presence of high risk HPV types 16 and 18 in cancer of the esophagus.

HUMAN PAPILLOMA VIRUS (HPV) IN SQUAMOUS CELL CARCINOMA OF THE OESOPHAGUS. - nil

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2011/05/001763
Enrollment
76
Registered
2011-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- HPV and Cancer of the oesophagus

Interventions

Control Intervention1: nil: nil

Sponsors

Fluid Research Grants
Lead Sponsor
Christian Medical College and Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All cases with Squamous cell cancer of the oesophagus.

Exclusion criteria

Exclusion criteria: (i) Patient who had previous treatment for carcinoma oesophagus. (ii) Immunocompromissed states (HIV ,Cirrhosis of liver, chronic renal failure, uncontrolled diabetes etc.)

Design outcomes

Primary

MeasureTime frame
presence or absence of High risk HPV types 16 and 18.Timepoint: 2 years

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Smit Kumar
drsmitkumar@rediffmail.com0416-2282079

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026